Clinical Trial

Extended vs. Intermittent Beta-Lactam Infusion in ICU Sepsis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This observational study compares extended versus intermittent beta-lactam infusion in sepsis patients, assessing survival, clinical cure rates, and practical ICU challenges. The findings will guide optimal antibiotic protocols, potentially improving sepsis outcomes through precision dosing strategies.
Trial Details
NCT Number NCT07398703
Lead Sponsor Assiut University
Conditions Sepsis, Septic Shock
Enrollment 50 participants
Start Date 2026-10
Primary Completion 2027-05 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-10